Nxera Pharma Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3431300007
JPY
843.00
22 (2.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sumitomo Pharma Co., Ltd.
Tsumura & Co.
Towa Pharmaceutical Co., Ltd.
Suzuken Co., Ltd.
Nippon Shinyaku Co., Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Mochida Pharmaceutical Co., Ltd.
JCR Pharmaceuticals Co., Ltd.
SAWAI GROUP HOLDINGS Co., Ltd.
Nxera Pharma Co., Ltd.
Kaken Pharmaceutical Co., Ltd.

Why is Nxera Pharma Co., Ltd. ?

1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 1.54%
2
The company has declared negative results in Jan 70 after 3 consecutive negative quarters
  • NET SALES(HY) At JPY 14,521 MM has Grown at -9.89%
  • ROCE(HY) Lowest at -19.35%
  • CASH AND EQV(HY) Lowest at JPY 48,826 MM
3
Risky - Negative Operating Profits
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -8.47%, its profits have risen by 73.4%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -8.47% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nxera Pharma Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Nxera Pharma Co., Ltd.
-8.47%
71.28
48.75%
Japan Nikkei 225
36.73%
1.30
28.24%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
31.83%
EBIT Growth (5y)
-252.78%
EBIT to Interest (avg)
-1.07
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.18
Tax Ratio
42.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.52%
ROE (avg)
1.54%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.27
EV to EBIT
-20.00
EV to EBITDA
-70.53
EV to Capital Employed
1.19
EV to Sales
3.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.96%
ROE (Latest)
-3.45%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
OPERATING CASH FLOW(Y)

Highest at JPY -2,668 MM

RAW MATERIAL COST(Y)

Fallen by -6.8% (YoY

-35What is not working for the Company
NET SALES(HY)

At JPY 14,521 MM has Grown at -9.89%

ROCE(HY)

Lowest at -19.35%

CASH AND EQV(HY)

Lowest at JPY 48,826 MM

DEBT-EQUITY RATIO (HY)

Highest at 60.68 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.81 times

INTEREST(Q)

Highest at JPY 5,764 MM

PRE-TAX PROFIT(Q)

Lowest at JPY -8,112 MM

NET PROFIT(Q)

Lowest at JPY -7,721 MM

EPS(Q)

Lowest at JPY -85.48

Here's what is working for Nxera Pharma Co., Ltd.

Operating Cash Flow
Highest at JPY -2,668 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (JPY MM)

Raw Material Cost
Fallen by -6.8% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nxera Pharma Co., Ltd.

Pre-Tax Profit
At JPY -8,112 MM has Fallen at -242.42%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit
At JPY -7,721 MM has Fallen at -478.35%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (JPY MM)

Interest
At JPY 5,764 MM has Grown at 2,725.49%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Net Sales
At JPY 14,521 MM has Grown at -9.89%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (JPY MM)

Interest
Highest at JPY 5,764 MM
in the last five periods and Increased by 2,725.49% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Pre-Tax Profit
Lowest at JPY -8,112 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit
Lowest at JPY -7,721 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

EPS
Lowest at JPY -85.48
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Cash and Eqv
Lowest at JPY 48,826 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at 60.68 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 0.81 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio